Back to Search
NEAL LINDEMAN, MD
MD
Anatomic Pathology & Clinical Pathology Physician
NPI: 1699791681IndividualAccepts Medicare
Specialties, Licenses & Credentials
Molecular Genetic Pathology (Pathology) Physician
Pathology — Molecular Genetic Pathology
Code: 207ZP0007X
205475(MA)320088(NY)
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
205475(MA)320088(NY)
Chemical Pathology Physician
Pathology — Chemical Pathology
Code: 207ZP0104X
205475(MA)320088(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1990
Research & Publications (20)
Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissection.
PMID 12459634·Diagn Mol Pathol·2002
8-other
EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.
PMID 19347832·Cancer·2009
8-other
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.
PMID 19671850·Clin Cancer Res·2009
8-other
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.
PMID 18594010·Clin Cancer Res·2008
8-other
Intravascular cytotoxic T-cell lymphoma: A case report and review of the literature.
PMID 18222325·J Am Acad Dermatol·2008
5-case
Immunosuppressant monitoring can be performed by UPLC-Tandem Mass Spectrometry in half the time needed for conventional HPLC-Tandem Mass Spectrometry, with comparable analytical performance.
PMID 18023420·Clin Chim Acta·2008
4-observational
Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male.
PMID 19669271·Hepatol Int·2008
8-other
Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers.
PMID 18980991·Clin Cancer Res·2008
8-other
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer.
PMID 17228019·J Clin Oncol·2007
3-trial
Selecting automation for the clinical chemistry laboratory.
PMID 17616992·Arch Pathol Lab Med·2007
8-other
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy.
PMID 17613438·Cancer Cell·2007
7-preclinical
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
PMID 17463250·Science·2007
7-preclinical
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.
PMID 17339482·J Immunol·2007
3-trial
Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.
PMID 16983123·J Clin Oncol·2006
5-case
Epidermal growth factor receptor mutation testing in the care of lung cancer patients.
PMID 16857818·Clin Cancer Res·2006
6-review
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.
PMID 16818686·Clin Cancer Res·2006
8-other
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing.
PMID 16799556·Nat Med·2006
8-other
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.
PMID 16467085·Clin Cancer Res·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 FRANCIS STREET AMORY 3, BRIGHAM AND WOMENS HOSPITAL DEPARTMENT OF PATHOLOGY
BOSTON, MA 02115 - Phone
- (617) 732-6790
Quick Facts
- NPI
- 1699791681
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 6
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile